APA

Falchi L., Baron J. M., Orlikowski C. A. & Ferrajoli A. (20160315). BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. : Mediterranean journal of hematology and infectious diseases.

Chicago

Falchi Lorenzo, Baron Jessica M, Orlikowski Carrie Anne and Ferrajoli Alessandra. 20160315. BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. : Mediterranean journal of hematology and infectious diseases.

Harvard

Falchi L., Baron J. M., Orlikowski C. A. and Ferrajoli A. (20160315). BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. : Mediterranean journal of hematology and infectious diseases.

MLA

Falchi Lorenzo, Baron Jessica M, Orlikowski Carrie Anne and Ferrajoli Alessandra. BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. : Mediterranean journal of hematology and infectious diseases. 20160315.